Does LENVATINIB Cause Respiratory tract infection? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Respiratory tract infection have been filed in association with LENVATINIB (Lenvima). This represents 0.1% of all adverse event reports for LENVATINIB.
18
Reports of Respiratory tract infection with LENVATINIB
0.1%
of all LENVATINIB reports
2
Deaths
15
Hospitalizations
How Dangerous Is Respiratory tract infection From LENVATINIB?
Of the 18 reports, 2 (11.1%) resulted in death, 15 (83.3%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Respiratory tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENVATINIB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Respiratory tract infection?
RITUXIMAB (1,058)
PREDNISONE (1,051)
OMALIZUMAB (927)
ADALIMUMAB (913)
METHOTREXATE (895)
ETANERCEPT (848)
HUMAN IMMUNOGLOBULIN G (764)
LENALIDOMIDE (731)
DEXAMETHASONE (684)
ALBUTEROL (601)
Which LENVATINIB Alternatives Have Lower Respiratory tract infection Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE